Outcomes of extended versus limited indications for patients undergoing a liver resection for colorectal cancer liver metastases

Nordlinger, 1996, Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Francaise de Chirurgie, Cancer, 77, 1254, 10.1002/(SICI)1097-0142(19960401)77:7<1254::AID-CNCR5>3.0.CO;2-I Fong, 1999, Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases, Ann Surg, 230, 309, 10.1097/00000658-199909000-00004 Altendorf-Hofmann, 2003, A critical review of the major indicators of prognosis after resection of hepatic metastases from colorectal carcinoma, Surg Oncol Clin N Am, 12, 165, 10.1016/S1055-3207(02)00091-1 Sharma, 2008, Management of hepatic metastasis from colorectal cancers: an update, J Hepatobiliary Pancreat Surg, 15, 570, 10.1007/s00534-008-1350-x Pawlik, 2006, Debunking dogma: surgery for four or more colorectal liver metastases is justified, J Gastrointest Surg, 10, 240, 10.1016/j.gassur.2005.07.027 Mehrabi, 2008, Mesohepatectomy as an option for the treatment of central liver tumors, J Am Coll Surg, 207, 499, 10.1016/j.jamcollsurg.2008.05.024 Pulitano, 2011, Liver resection for colorectal metastases in presence of extrahepatic disease: results from an international multi-institutional analysis, Ann Surg Oncol, 18, 1380, 10.1245/s10434-010-1459-4 Fong, 1999, Surgical therapy of hepatic colorectal metastasis, CA Cancer J Clin, 49, 231, 10.3322/canjclin.49.4.231 Pawlik, 2008, Expanding criteria for resectability of colorectal liver metastases, Oncologist, 13, 51, 10.1634/theoncologist.2007-0142 Shimada, 2009, Treatment for colorectal liver metastases: a review, Langenbecks Arch Surg, 394, 973, 10.1007/s00423-009-0530-8 Adam, 2000, Two-stage hepatectomy: a planned strategy to treat irresectable liver tumors, Ann Surg, 232, 777, 10.1097/00000658-200012000-00006 Gallagher, 2010, Metastatic colorectal cancer: from improved survival to potential cure, Oncology, 78, 237, 10.1159/000315730 Yang, 2010, Extending limits of resection for metastatic colorectal cancer: risk benefit ratio, J Surg Oncol, 102, 996, 10.1002/jso.21701 Razafindratsira, 2011, Complications of intraoperative radiofrequency ablation of liver metastases, HPB, 13, 15, 10.1111/j.1477-2574.2010.00243.x Evrard, 2012, Unresectable colorectal cancer liver metastases treated by intraoperative radiofrequency ablation with or without resection, Br J Surg, 99, 558, 10.1002/bjs.8665 Ruers, 2012, Radiofrequency ablation combined with systemic treatment versus systemic treatment alone in patients with non-resectable colorectal liver metastases: a randomized EORTC Intergroup phase II study (EORTC 40004), Ann Oncol, 23, 2619, 10.1093/annonc/mds053 Folprecht, 2010, Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial, Lancet Oncol, 11, 38, 10.1016/S1470-2045(09)70330-4 Lam, 2012, A systematic review of clinical response and survival outcomes of downsizing systemic chemotherapy and rescue liver surgery in patients with initially unresectable colorectal liver metastases, Ann Surg Oncol, 19, 1292, 10.1245/s10434-011-2061-0 Strasberg, 2005, Nomenclature of hepatic anatomy and resections: a review of the Brisbane 2000 system, J Hepatobiliary Pancreat Surg, 12, 351, 10.1007/s00534-005-0999-7 van de Poll, 2007, Interorgan amino acid exchange in humans: consequences for arginine and citrulline metabolism, Am J Clin Nutr, 85, 167, 10.1093/ajcn/85.1.167 van Dam, 2008, Initial experience with a multimodal enhanced recovery programme in patients undergoing liver resection, Br J Surg, 95, 969, 10.1002/bjs.6227 van den Broek, 2011, Development of a composite endpoint for randomized controlled trials in liver surgery, Br J Surg, 98, 1138, 10.1002/bjs.7503 Marang-van de Mheen, 2006, Adverse outcomes in surgical patients: implementation of a nationwide reporting system, Qual Saf Health Care, 15, 320, 10.1136/qshc.2005.016220 Dindo, 2004, Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey, Ann Surg, 240, 205, 10.1097/01.sla.0000133083.54934.ae de Haas, 2011, Impact of expanding criteria for resectability of colorectal metastases on short- and long-term outcomes after hepatic resection, Ann Surg, 253, 1069, 10.1097/SLA.0b013e318217e898 Pawlik, 2005, Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases, Ann Surg, 241, 715, 10.1097/01.sla.0000160703.75808.7d de Jong, 2009, Rates and patterns of recurrence following curative intent surgery for colorectal liver metastasis: an international multi-institutional analysis of 1669 patients, Ann Surg, 250, 440, 10.1097/SLA.0b013e3181b4539b Kanas, 2012, Survival after liver resection in metastatic colorectal cancer: review and meta-analysis of prognostic factors, Clin Epidemiol, 4, 283 Saltz, 2008, Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study, J Clin Oncol, 26, 2013, 10.1200/JCO.2007.14.9930 van Iersel, 2010, Management of isolated nonresectable liver metastases in colorectal cancer patients: a case-control study of isolated hepatic perfusion with melphalan versus systemic chemotherapy, Ann Oncol, 21, 1662, 10.1093/annonc/mdp589 Cassidy, 2011, XELOX vs FOLFOX-4 as first-line therapy for metastatic colorectal cancer: NO16966 updated results, Br J Cancer, 105, 58, 10.1038/bjc.2011.201 Maughan, 2011, Addition of cetuximab to oxaliplatin-based first-line combination chemotherapy for treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial, Lancet, 377, 2103, 10.1016/S0140-6736(11)60613-2 Wiering, 2011, Long-term global quality of life in patients treated for colorectal liver metastases, Br J Surg, 98, 565, 10.1002/bjs.7365 Langenhoff, 2006, Quality of life after surgical treatment of colorectal liver metastases, Br J Surg, 93, 1007, 10.1002/bjs.5387 Farges, 2012, Incidence and risks of liver resection: an all-inclusive French nationwide study, Ann Surg, 256, 697, 10.1097/SLA.0b013e31827241d5 Schiesser, 2008, Perioperative morbidity affects long-term survival in patients following liver resection for colorectal metastases, J Gastrointest Surg, 12, 1054, 10.1007/s11605-007-0438-y Abbott, 2013, Short-term outcomes after combined colon and liver resection for synchronous colon cancer liver metastases: a population study, Ann Surg Oncol, 20, 139, 10.1245/s10434-012-2515-z Vente, 2009, Yttrium-90 microsphere radioembolization for the treatment of liver malignancies: a structured meta-analysis, Eur Radiol, 19, 951, 10.1007/s00330-008-1211-7 Schnitzbauer, 2012, Right portal vein ligation combined with in situ splitting induces rapid left lateral liver lobe hypertrophy enabling 2-staged extended right hepatic resection in small-for-size settings, Ann Surg, 255, 405, 10.1097/SLA.0b013e31824856f5 Knoefel, 2013, In situ liver transection with portal vein ligation for rapid growth of the future liver remnant in two-stage liver resection, Br J Surg, 100, 388, 10.1002/bjs.8955 Neumann, 2013, Split decision, Br J Surg, 100, 310, 10.1002/bjs.9050